The Journal of Immunology, Vol 150, Issue 10 4303-4314, Copyright © 1993 by American Association of Immunologists

ARTICLES

Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis

A Ratner and WR Clark
Department of Anatomy and Cell Biology, University of California, Los Angeles 90024.

The possibility that lymphokines such as TNF-alpha produced by CD8+ CTL are responsible for acute (short term) target cell damage induced by CTL has been debated for many years. However, the slow kinetics of TNF- induced target cell death stands in sharp contrast to the rapid target cell lysis mediated by CTL. We find that cloned CD8+ CTL activated through their TCR secrete TNF-alpha. On the other hand, our cloned CTL also have a membrane form of TNF-alpha, and they kill TNF-alpha- sensitive target cells not recognized through the TCR in a slow (18-h) lytic reaction using this surface-associated TNF-alpha. There is no secreted TNF-alpha release during this interaction. Cyclosporin A and protein synthesis inhibitors block TNF-alpha secretion, but have no effect on slow lysis mediated by the CTL. On the other hand, TNF-alpha- resistant variants are greatly resistant to slow lysis, and antibodies to TNF-alpha strongly inhibit this slow lysis. Thus, although secreted TNF-alpha does not seem to be the mechanism behind slow lysis, some form of TNF-alpha, most likely the membrane-associated form, must be involved. Not only does surface TNF-alpha appear to be biologically active in these CTL, but its expression is enhanced severalfold upon activation of the CTL through the TCR. This may be important in vivo, where surface TNF-alpha could preserve the localized nature of cytolysis and endow a CTL with an additional, albeit slower, mechanism of cell lysis. Finally, we find that although activated CTL clearly use the membrane form of TNF-alpha in slow lysis, they appear not to use TNF-alpha, in any form, during acute lysis, even under conditions in which degranulation and perforin assembly are blocked.

This article has been cited by other articles:

				D. S. Dace, P. W. Chen, and J. Y. Niederkorn CD8+ T Cells Circumvent Immune Privilege in the Eye and Mediate Intraocular Tumor Rejection by a TNF-{alpha}-Dependent Mechanism J. Immunol., May 15, 2007; 178(10): 6115 - 6122. [Abstract] [Full Text] [PDF]

				A. Hombach, H. Kohler, G. Rappl, and H. Abken Human CD4+ T Cells Lyse Target Cells via Granzyme/Perforin upon Circumvention of MHC Class II Restriction by an Antibody-Like Immunoreceptor J. Immunol., October 15, 2006; 177(8): 5668 - 5675. [Abstract] [Full Text] [PDF]

				M. E. Dobbs, J. E. Strasser, C.-F. Chu, C. Chalk, and G. N. Milligan Clearance of Herpes Simplex Virus Type 2 by CD8+ T Cells Requires Gamma Interferon and either Perforin- or Fas-Mediated Cytolytic Mechanisms J. Virol., December 1, 2005; 79(23): 14546 - 14554. [Abstract] [Full Text] [PDF]

				J. Liu, M. Q. Zhao, L. Xu, C. V. Ramana, W. Declercq, P. Vandenabeele, and R. I. Enelow Requirement for Tumor Necrosis Factor-Receptor 2 in Alveolar Chemokine Expression Depends upon the Form of the Ligand Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 463 - 469. [Abstract] [Full Text] [PDF]

				M. Gonthier, R. Llobera, J. Arnaud, and B. Rubin Self-Reactive T Cell Receptor-Reactive CD8+ T Cells Inhibit T Cell Lymphoma Growth In Vivo J. Immunol., December 1, 2004; 173(11): 7062 - 7069. [Abstract] [Full Text] [PDF]

				S. Bauer, N. Adrian, B. Williamson, C. Panousis, N. Fadle, J. Smerd, I. Fettah, A. M. Scott, M. Pfreundschuh, and C. Renner Targeted Bioactivity of Membrane-Anchored TNF by an Antibody-Derived TNF Fusion Protein J. Immunol., March 15, 2004; 172(6): 3930 - 3939. [Abstract] [Full Text] [PDF]

				L. Beloeil, M. Tomkowiak, G. Angelov, T. Walzer, P. Dubois, and J. Marvel In Vivo Impact of CpG1826 Oligodeoxynucleotide on CD8 T Cell Primary Responses and Survival J. Immunol., September 15, 2003; 171(6): 2995 - 3002. [Abstract] [Full Text] [PDF]

				A. Bose, Y. Inoue, K. E. Kokko, and F. G. Lakkis Cutting Edge: Perforin Down-Regulates CD4 and CD8 T Cell-Mediated Immune Responses to a Transplanted Organ J. Immunol., February 15, 2003; 170(4): 1611 - 1614. [Abstract] [Full Text] [PDF]

				D. J. Adamko, A. D. Fryer, B. S. Bochner, and D. B. Jacoby CD8+ T Lymphocytes in Viral Hyperreactivity and M2 Muscarinic Receptor Dysfunction Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 550 - 556. [Abstract] [Full Text] [PDF]

				C. S. Via, A. Shustov, V. Rus, T. Lang, P. Nguyen, and F. D. Finkelman In Vivo Neutralization of TNF-{alpha} Promotes Humoral Autoimmunity by Preventing the Induction of CTL J. Immunol., December 15, 2001; 167(12): 6821 - 6826. [Abstract] [Full Text] [PDF]

				H. Zhou, T. B. Stuge, N. W. Miller, E. Bengten, J. P. Naftel, J. M. Bernanke, V. G. Chinchar, L. W. Clem, and M. Wilson Heterogeneity of Channel Catfish CTL with Respect to Target Recognition and Cytotoxic Mechanisms Employed J. Immunol., August 1, 2001; 167(3): 1325 - 1332. [Abstract] [Full Text] [PDF]

				C. N. Baxevanis, I. F. Voutsas, O. E. Tsitsilonis, A. D. Gritzapis, R. Sotiriadou, and M. Papamichail Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor J. Immunol., April 1, 2000; 164(7): 3902 - 3912. [Abstract] [Full Text] [PDF]

				A. N. Liu, A. Z. Mohammed, W. R. Rice, D. T. Fiedeldey, J. S. Liebermann, J. A. Whitsett, T. J. Braciale, and R. I. Enelow Perforin-Independent CD8+ T-Cell-Mediated Cytotoxicity of Alveolar Epithelial Cells Is Preferentially Mediated by Tumor Necrosis Factor-alpha . Relative Insensitivity to Fas Ligand Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 849 - 858. [Abstract] [Full Text]

				J. Spielman, R. K. Lee, and E. R. Podack Perforin/Fas-Ligand Double Deficiency Is Associated with Macrophage Expansion and Severe Pancreatitis J. Immunol., December 15, 1998; 161(12): 7063 - 7070. [Abstract] [Full Text] [PDF]

				M. Ameyar, A. Atfi, Z. Cai, R. Stancou, V. Shatrov, A. Bettaieb, and S. Chouaib Analysis of Human Breast Adenocarcinoma MCF7 Resistance to Tumor Necrosis Factor-induced Cell Death. LACK OF CORRELATION BETWEEN JNK ACTIVATION AND CERAMIDE PATHWAY J. Biol. Chem., October 30, 1998; 273(44): 29002 - 29008. [Abstract] [Full Text] [PDF]

				W. Stohl, D. H. Lynch, G. C. Starling, and P. A. Kiener Superantigen-Driven, CD8+ T Cell-Mediated Down-Regulation: CD95 (Fas)-Dependent Down-Regulation of Human Ig Responses Despite CD95-Independent Killing of Activated B Cells J. Immunol., October 1, 1998; 161(7): 3292 - 3298. [Abstract] [Full Text] [PDF]